For over five decades, BSV has developed a range of biological, biotech, and pharmaceutical products for women’s health, infertility (IUI/IVF), and critical, and emergency care.
“At BSV, we remain committed to innovation and research to deliver treatments and cures that serve our patients better,” said Dr. Swashraya Shah, Chief Medical Officer at BSV. “With Vault PromoMats, organizations now have the ability to prioritize and share scientific digital content with physicians in real time, while ensuring compliance and effective data asset management. Vault PromoMats also assists in content analytics to increase effectiveness.”
“We’re excited that BSV has standardized on Vault PromoMats to easily publish approved assets to digital channels and to accelerate its time to market through content reuse,” said Anantha Nema, India country manager, Veeva Systems. “With a digital content platform, biopharmas in India can optimize their promotional material review cycles to keep up with the increased demand for timely information.”
Vault PromoMats helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials. Marketing teams can easily publish and withdraw content from digital channels as needed to ensure only approved assets are in use. Vault PromoMats also supports accelerated content approval and time to market through streamlined medical, legal, and regulatory reviews, and offers visibility into industry benchmarks and activities across assets to drive content strategy.
Additional Information
For more on Veeva Vault PromoMats, visit: veeva.com/PromoMats
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
